VIVA! AE survives Dry July

Here at VIVA! we take health and wellness very seriously, which is why this month our fabulous Account Executive, Ben Pike, decided to participate in ‘Dry July’, a fundraiser that encourages you to go alcohol free for one whole month to raise money for people affected by cancer. VIVA! has worked over the years with…

Read More

NSANZ secures charity status and appoints new President

VIVA! Communications is delighted to be teaming with the Neuromodulation Society of Australia and New Zealand (NSANZ) today (Tuesday, July 30, 2019) to announce their approved charity status, and appointment of their new President. The peak professional body for the practice of neuromodulation has been recognised for its invaluable role in striving to uphold the…

Read More

New blood cancer therapy granted TGA approval

There was some promising news for the Australian multiple myeloma community this month with the Therapeutic Goods Administration (TGA) approval of a new triplet therapy. Myeloma is a life-threatening blood cancer, not to be confused with the skin cancer, melanoma. It develops from plasma cells typically found in the bone marrow and can affect multiple…

Read More

VIVA! Communications is celebrating 17 successful years

VIVA! is celebrating 17 years in business today, reinforcing our commitment to excellence and innovation in the healthcare arena. The birthday celebrations follow VIVA!s recent office expansion of our existing headquarters in Mosman, Sydney, following an influx of new healthcare clientele. Established in 2002 by Principal, Fellow of the Public Relations Institute of Australia (PRIA)…

Read More

A pharmacist’s perspective on pneumococcal pneumonia

Pneumococcal pneumonia results in more than 77,000 hospitalisations and 4,000 deaths8 in Australia each year. Many of us carry pneumonia-causing bacteria in the back of our throats, which can take hold when the immune system becomes compromised or due to a viral infection such as the flu. Australians aged over 65 years are at significantly…

Read More